Last month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…

Juan Andres Biography and Net Worth

Insider of Moderna

As Chief Technical Operations and Quality Officer, Juan Andres is responsible for the supply of product required for Moderna’s preclinical and clinical development programs, as well as scaling the CMC (chemistry, manufacturing and controls) processes across Moderna’s portfolio. Mr. Andres also will lead all CMC late-stage development and future commercialization activities.

Mr. Andres was previously the Global Head of Technical Operations (Manufacturing and Supply Chain) for over 25,000 Novartis employees across all of its divisions. In this role, he had responsibility for all of Novartis’ manufacturing sites, and related support functions and technologies worldwide, overseeing small molecules drug substance and drug product, as well as biologics drug substance, drug product and technical development. Mr. Andres’ previous roles at Novartis included Group Novartis Quality Head, Global Head of Technical Research and Development, and Global Pharmaceutical Operations Head. Prior to Novartis, Mr. Andres worked at Eli Lilly & Co. for 18 years in a variety of manufacturing, production and quality roles in the United States, Puerto Rico, UK and Spain, most recently serving as Vice President, Pharmaceutical Manufacturing.

Mr. Andres holds a Master degree in Pharmacy from Alcala de Henares University in Madrid and completed an advanced development program at the London Business School.

What is Juan Andres' net worth?: The estimated net worth of Juan Andres is at least $526,331.33 as of December 28th, 2022. Mr. Andres owns 12,803 shares of Moderna stock worth more than $526,331 as of November 22nd. This net worth evaluation does not reflect any other assets that Mr. Andres may own. Learn More about Juan Andres' net worth.
How do I contact Juan Andres?: The corporate mailing address for Mr. Andres and other Moderna executives is 200 TECHNOLOGY SQUARE, CAMBRIDGE MA, 02139. Moderna can also be reached via phone at (617) 714-6500 and via email at [email protected]. Learn More on Juan Andres' contact information.
Has Juan Andres been buying or selling shares of Moderna?: Juan Andres has not been actively trading shares of Moderna within the last three months. Most recently, Juan Andres sold 2,000 shares of the business's stock in a transaction on Wednesday, December 28th. The shares were sold at an average price of $180.00, for a transaction totalling $360,000.00. Following the completion of the sale, the insider now directly owns 12,803 shares of the company's stock, valued at $2,304,540. Learn More on Juan Andres' trading history.
Who are Moderna's active insiders?: Moderna's insider roster includes Noubar Afeyan (Director), Juan Andres (Insider), Stephane Bancel (Chief Executive Officer), W. Cornwell (Director), Arpa Garay (Insider), Lori Henderson (General Counsel), Lori Henderson (General Counsel), Stephen Hoge (President), Lorence Kim (CFO), Shannon Klinger (Insider), David Meline (CFO), Jamey Mock (CFO), Elizabeth Nabel (Director), Paul Sagan (Director), and Tal Zaks (Insider). Learn More on Moderna's active insiders.
Are insiders buying or selling shares of Moderna?: During the last year, insiders at the sold shares 46 times. They sold a total of 646,276 shares worth more than $81,357,882.30. The most recent insider tranaction occured on October, 7th when CFO James M Mock sold 715 shares worth more than $42,985.80. Insiders at Moderna own 15.7% of the company. Learn More about insider trades at Moderna.
Information on this page was last updated on 10/7/2024.

Juan Andres Insider Trading History at Moderna

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/28/2022	Sell	2,000	$180.00	$360,000.00	12,803
12/21/2022	Sell	2,000	$201.70	$403,400.00	12,803
12/7/2022	Sell	2,000	$172.16	$344,320.00	12,803
11/29/2022	Sell	814	$173.80	$141,473.20	12,803
11/23/2022	Sell	2,000	$178.01	$356,020.00	11,809
11/2/2022	Sell	2,000	$154.20	$308,400.00	11,566
10/28/2022	Sell	4,000	$150.00	$600,000.00	11,566
8/29/2022	Sell	839	$135.81	$113,944.59	11,566
8/17/2022	Sell	2,000	$165.24	$330,480.00	10,598
8/10/2022	Sell	2,204	$174.05	$383,606.20	10,598
8/3/2022	Sell	2,000	$167.99	$335,980.00	10,367
7/27/2022	Sell	2,000	$161.00	$322,000.00	10,367
7/20/2022	Sell	2,000	$167.00	$334,000.00	10,367
7/13/2022	Sell	2,000	$168.88	$337,760.00	10,367
7/6/2022	Sell	2,000	$154.85	$309,700.00	10,367
7/1/2022	Sell	6,000	$150.00	$900,000.00	10,367
5/31/2022	Sell	749	$145.40	$108,904.60	10,367
5/10/2022	Sell	195	$133.71	$26,073.45	9,309
5/4/2022	Sell	2,000	$153.23	$306,460.00	9,069
4/29/2022	Sell	2,000	$150.00	$300,000.00	9,069
4/20/2022	Sell	2,000	$153.00	$306,000.00	9,069
4/13/2022	Sell	2,000	$158.37	$316,740.00	9,069
4/6/2022	Sell	2,000	$157.50	$315,000.00	9,069
3/30/2022	Sell	2,000	$182.79	$365,580.00
3/23/2022	Sell	2,000	$184.66	$369,320.00
3/16/2022	Sell	2,000	$150.01	$300,020.00
2/24/2022	Sell	2,000	$150.00	$300,000.00
2/16/2022	Sell	2,000	$150.00	$300,000.00
2/9/2022	Sell	2,000	$154.26	$308,520.00
2/2/2022	Sell	2,000	$170.89	$341,780.00
12/29/2021	Sell	5,000	$240.00	$1,200,000.00
12/27/2021	Sell	10,000	$243.10	$2,431,000.00
12/22/2021	Sell	5,000	$264.26	$1,321,300.00
12/20/2021	Sell	15,000	$320.97	$4,814,550.00
12/17/2021	Sell	5,000	$275.68	$1,378,400.00
12/15/2021	Sell	5,000	$272.11	$1,360,550.00
12/13/2021	Sell	5,000	$257.01	$1,285,050.00
12/10/2021	Sell	5,000	$235.00	$1,175,000.00
12/8/2021	Sell	5,000	$282.35	$1,411,750.00
12/6/2021	Sell	15,000	$280.60	$4,209,000.00
12/3/2021	Sell	5,000	$318.40	$1,592,000.00
11/29/2021	Sell	5,000	$370.38	$1,851,900.00
11/26/2021	Sell	5,000	$319.62	$1,598,100.00
11/24/2021	Sell	5,000	$273.01	$1,365,050.00
11/22/2021	Sell	15,000	$268.18	$4,022,700.00
11/19/2021	Sell	5,000	$265.71	$1,328,550.00
11/17/2021	Sell	5,000	$234.57	$1,172,850.00
11/15/2021	Sell	5,000	$231.01	$1,155,050.00
11/10/2021	Sell	5,000	$230.00	$1,150,000.00
11/8/2021	Sell	15,000	$233.13	$3,496,950.00
11/5/2021	Sell	5,000	$240.00	$1,200,000.00
11/1/2021	Sell	5,000	$335.00	$1,675,000.00
10/29/2021	Sell	5,000	$344.49	$1,722,450.00
10/27/2021	Sell	5,000	$344.25	$1,721,250.00
10/25/2021	Sell	15,000	$327.36	$4,910,400.00
10/22/2021	Sell	5,000	$333.00	$1,665,000.00
10/20/2021	Sell	5,000	$333.90	$1,669,500.00
10/18/2021	Sell	5,000	$322.26	$1,611,300.00
10/15/2021	Sell	5,000	$341.25	$1,706,250.00
10/13/2021	Sell	5,000	$314.90	$1,574,500.00
10/6/2021	Sell	5,000	$318.23	$1,591,150.00
9/29/2021	Sell	5,000	$393.44	$1,967,200.00
9/27/2021	Sell	15,000	$429.38	$6,440,700.00
9/27/2021	Sell	15,000	$429.38	$6,440,700.00
9/22/2021	Sell	5,000	$433.00	$2,165,000.00
9/20/2021	Sell	5,000	$417.62	$2,088,100.00
9/17/2021	Sell	5,000	$438.24	$2,191,200.00
9/15/2021	Sell	5,000	$427.13	$2,135,650.00
9/13/2021	Sell	15,000	$447.41	$6,711,150.00
9/10/2021	Sell	5,000	$461.85	$2,309,250.00	5,000
9/1/2021	Sell	5,000	$381.82	$1,909,100.00
8/30/2021	Sell	15,000	$368.93	$5,533,950.00
8/27/2021	Sell	5,000	$398.12	$1,990,600.00	5,000
8/25/2021	Sell	5,000	$391.59	$1,957,950.00
8/18/2021	Sell	5,000	$407.00	$2,035,000.00	5,000
8/13/2021	Sell	5,000	$405.00	$2,025,000.00	5,000
8/4/2021	Sell	5,000	$384.85	$1,924,250.00	5,000
7/28/2021	Sell	5,000	$332.92	$1,664,600.00
7/23/2021	Sell	5,000	$330.90	$1,654,500.00	5,000
7/21/2021	Sell	5,000	$299.00	$1,495,000.00	5,000
7/19/2021	Sell	15,000	$284.40	$4,266,000.00
7/16/2021	Sell	5,000	$276.51	$1,382,550.00
7/14/2021	Sell	5,000	$237.22	$1,186,100.00
7/12/2021	Sell	5,000	$230.71	$1,153,550.00
7/6/2021	Sell	5,000	$229.62	$1,148,100.00
6/23/2021	Sell	5,000	$219.65	$1,098,250.00	5,000
6/21/2021	Sell	5,000	$200.86	$1,004,300.00	5,000
6/14/2021	Sell	5,000	$213.32	$1,066,600.00	5,000
6/7/2021	Sell	5,000	$207.04	$1,035,200.00	5,000
5/17/2021	Sell	5,000	$159.23	$796,150.00
5/5/2021	Sell	5,000	$178.34	$891,700.00	5,000
5/3/2021	Sell	5,000	$183.66	$918,300.00
4/28/2021	Sell	5,000	$182.32	$911,600.00	5,000
4/26/2021	Sell	5,000	$171.77	$858,850.00	5,000
4/21/2021	Sell	5,000	$158.60	$793,000.00	5,000
4/19/2021	Sell	5,000	$166.17	$830,850.00	5,000
4/14/2021	Sell	5,000	$153.75	$768,750.00	5,000
4/7/2021	Sell	5,000	$131.63	$658,150.00	5,000
3/31/2021	Sell	5,000	$121.10	$605,500.00
3/29/2021	Sell	5,000	$130.05	$650,250.00	5,000
3/17/2021	Sell	5,000	$149.78	$748,900.00	5,000
3/10/2021	Sell	5,000	$133.24	$666,200.00	5,000
2/1/2021	Sell	5,000	$172.99	$864,950.00	5,000
1/11/2021	Sell	5,000	$112.83	$564,150.00	5,000
5/13/2020	Sell	127,500	$64.67	$8,245,425.00	127,500
5/1/2020	Sell	25,000	$48.05	$1,201,250.00	25,000
4/15/2020	Sell	23,403	$37.11	$868,485.33	23,403
4/6/2020	Sell	300	$35.13	$10,539.00	300

Juan Andres Buying and Selling Activity at Moderna

Moderna Company Overview

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $41.11

$37.76

$42.40

50 Day Range

MA: $55.50

$36.85

$71.99

2 Week Range

Now: $41.11

$35.80

$170.47

Volume

13,402,932 shs

Average Volume

4,838,952 shs

Market Capitalization

$15.82 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.69

⭕ [URGENT] Buy Alert just triggered

From Behind the Markets | Ad

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>